Study of a needleless intermittent intravenous-access system for peripheral infusions: Analysis of staff, patient, and institutional outcomes

Infection Control and Hospital Epidemiology

Volumn 19, Issue 6, 1998, Pages 401-406

  Mendelson, Meryl H ^a,c   Short, Louise J ^a   Schechter, Clyde B ^a   Meyers, Burt R ^a   Rodriguez, Margarita ^a   Cohen, Sandra ^a   Lozada, John ^b   DeCambre, Marvalyn ^b   Hirschman, Shalom Z ^a  

^a MOUNT SINAI HOSPITAL   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ARTICLE; CLINICAL TRIAL; CROSS INFECTION; CROSSOVER PROCEDURE; DISEASE TRANSMISSION; HOSPITAL PERSONNEL; HUMAN; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NEEDLESTICK INJURY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; UNITED STATES;

ANTICOAGULANTS; CROSS INFECTION; CROSS-OVER STUDIES; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEPARIN; HUMANS; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; NEEDLESTICK INJURIES; NEW YORK; PERSONNEL, HOSPITAL;

EID: 0032085958     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30142428     Document Type: Article

References (26)

1. Department of Labor, Occupational Safety and Health Administration Standard: 1910-1030. Bloodborne pathogens. Federal Register December 6, 1991;56:64175-64182.
2. Benson JS. Needlestick and other risks from hypodermic needles on secondary IV, administration sets - piggyback and intermittent IV. Department of Health and Human Services Public Health Service, Food and Drug Administration. FDA Safety Alert, April 16, 1992.
3. Mendelson MH, Short LJ, Dong JU, Solomon J, Meyer BR, Hirschman SZ. Analysis of sharps injuries at an 1,100 bed teaching medical center: priorities for injury reducing devices. In: Proceedings of 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago IL. Washington, DC: American Society for Microbiology; 1991.
4. Occupational Safety and Health Administration. Jane Doe, San Francisco General Hospital; Service Employees International Union, Holiday Inn, Union Square, January 16, 1990. Exhibit no. 214-F. OSHA transcript from informal public hearing. Proposed rule on occupational exposure to bloodborne pathogens, pages 693-699.
5. Simmons BP, Hooton T, Wong ES, Allen JR. Guidelines for prevention of intravenous therapy related infections. Centers for Disease Control, October 1981.
6. Chiarello L, Nagin D, Laufer F. Pilot study of needlestick prevention devices: report to the legislature. Albany, NY: New York State Department of Health, March 1992.
7. Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: A prospective comparison of 645 vialon and teflon cannulae in anaesthetic and postoperative use. Anaesth Intensive Care 1988;16:265-271.
8. Mckee JM, Shell A, Warren TA, Campbell, VP. Complications of intravenous therapy: a randomized prospective study - vialon vs teflon. J Intraven Nurs 1989;127(5):288-297.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definition for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
10. Short LJ, Mendelson MH, Rosa M, Fallick N, Hirschman SZ. Economic implications of accidental needlestick injuries (NSI) at a large urban hospital. In: Proceedings of 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, Washington DC: American Society of Microbiology; 1991.
11. Juliett E, Jagger J, Chen ML. Projected reduction of needlestick injuries by substitution of safer devices. In: A National Conference on Prevention of Device Mediated Bloodborne Infections, Occupational Safety and Health Administration. Frontline Healthcare Workers conference. Washington, DC; August 1992; Abstract E-510.
12. Mendelson MH, Short L. Godbold J, Schechter C, Wu X, Meyers BR, et al. Multivariate analysis of needlestick/sharps injuries (SIs) - 10 New York State Hospitals, 1991. In: Proceedings of Third Annual Meeting of the Society for Hospital Epidemiology of America; Chicago, IL; 1993.
13. Gartner K. Impact of a needleless intravenous system in a university hospital. Am J Infect Control 1992;20:75-79.
14. Skolnick K, LaRocca J, Barbra D, Paicius L. Evaluation and implementation of a needleless intravenous system: making needlesticks a needless problem. Am J Infect Control 1993;21:39-41.
15. Rutowski J, Peterson SL. A needleless intravenous system: an effective risk management strategy. Infect Control Hosp Epidemiol 1993;14: 226-227.
16. Orenstein R, Reynolds L, Karabaic M, Lamb A, Markowitz SM, Wong ES. Do protective devices prevent needlestick injuries among health care workers? Am J Infect Control 1995; 23: 344-351.
17. Ippolito G, Decari G, Puro V, Petrosillo N, Arid C, Bertucci R, et al. Device-specific risk of needlestick injury in Italian health care workers. JAMA 1994;272:607-610.
18. Manian FA, Meyer L, Jenne J. Puncture injuries due to needles removed from intravenous lines: should the source patient routinely be tested for blood borne infections? Infect Control Hosp Epidemiol 1993;14:325-330.
19. Gerberding JL. Needlestick prevention: new paradigms for research. Infect Control Hosp Epidemiol 1992;13:257-258.
20. Adams KS, Zehrer CL, Thomas W. Comparison of a needleless system with conventional heparin locks. Am J Infect Control 1993;21:263-269.
21. Maki DG, Stolz S, McCormick R, Spiegel C. Possible association of a commercial needleless system with central venous catheter-related bacteremia. In: Proceedings of 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando Fla. Washington, DC: American Society for Microbiology; October 4-7, 1994. Abstract J 201.
22. Danzig LE, Short LJ, Collins K, Mahoney M, Sepi S, Blariel L, et al. Bloodstream infections associated with a needleless intravenous infusions system in patients receiving home infusion therapy. JAMA 1995;273:1862-1864.
23. Kellerman S, Shay D, Howard J, Feusner J, Goes C, Jarvis W, et al. Bloodstream infections associated with needleless devices used for central versus catheter access in children receiving home health care. In: Proceedings of 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. American Society for Microbiology; September 17-20, 1995. Abstract J 11.
24. Chodoff A, Pettis A, Schoonmaker D, Shelly M. Polymicrobial gram-negative bacteremia associated with saline solution flush used with a needleless intravenous system. Am J Infect Control 1995; 23:357-363.
25. McDonald LC, Banerjee S, Jarvis W. Central venous catheter (CVC)-associated bloodstream infections (BSI) in intensive care unit patients associated with needleless access devices. Infect Control Hosp Epidemiol 1997;18:24.
26. Centers for Disease Control and Prevention. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures - Minneapolis - St. Paul, New York City, and San Francisco, 1993-1995. MMWR 1997;46:21-25.